Australian swimmer James Magnussen finished in last place in both the 100-meter and 50-meter freestyle events at the inaugural Enhanced Games on Monday [1, 2, 3].
The results challenge the premise of the competition, which allows athletes to use performance-enhancing drugs under medical supervision to push human limits.
Magnussen entered the competition after two years of supervised doping [1, 2]. Despite this preparation, he failed to secure a podium finish in either of his events, finishing last in the 100-meter freestyle [1] and last in the 50-meter freestyle [1].
Kristian Gkolomeev won the 100-meter freestyle with a time of 46.6 seconds [3]. While this performance was strong, it did not break the world record of 46.4 seconds, which was set by Pan Zhanle [3].
Magnussen received a payment of $50,000 for his appearance at the event [1]. When discussing the competition, Magnussen said he was "not talking about Cam" [2].
The event marks the first time a major multi-sport competition has explicitly permitted the use of prohibited substances, moving away from the strict anti-doping protocols maintained by the Olympic Games. The poor performance of high-profile athletes like Magnussen raises questions about the actual efficacy of the supervised doping regimens used by participants.
“Magnussen finished in last place in both the 100-meter and 50-meter freestyle events.”
The failure of a seasoned athlete to improve or maintain competitiveness despite a two-year supervised doping cycle suggests that pharmaceutical enhancement is not a guaranteed shortcut to victory. It indicates that natural talent, training, and individual biological responses to PEDs remain significant variables, potentially undermining the Enhanced Games' marketing as a showcase for 'superhuman' performance.
